Civic Intelligence

A Cure for Ellie

990EZ • Fiscal year 2013 • EIN 46-2829156

Jan 01, 2013 to Dec 31, 2013

Arlington, VA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Liabilities / Revenue

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Net Margin

98th percentile

96%

Higher net margin than 98% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2013

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

$17,253

No earlier filing loaded for comparison.

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$17,995

No earlier filing loaded for comparison.

Expenses

$743

No earlier filing loaded for comparison.

Net Income

$17,252

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.0M$500K$0Assets 2013: $17,253Liabilities 2013: $02013Assets 2017: $44,532Liabilities 2017: $0Net Assets 2017: $44,5302017Assets 2018: $43,192Liabilities 2018: $0Net Assets 2018: $43,1922018Assets 2019: $71,272Liabilities 2019: $0Net Assets 2019: $71,2722019Assets 2020: $260,193Liabilities 2020: $0Net Assets 2020: $260,1932020Assets 2021: $444,924Liabilities 2021: $0Net Assets 2021: $444,9242021Assets 2022: $535,129Liabilities 2022: $0Net Assets 2022: $535,1292022Assets 2023: $739,400Liabilities 2023: $0Net Assets 2023: $739,4002023Assets 2024: $955,625Liabilities 2024: $0Net Assets 2024: $955,6252024

Highlighted filing

2013

Assets$17,253
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$2.0M$1.5M$1.0M$500K$0-$500KRevenue 2013: $17,995Expenses 2013: $743Net Income 2013: $17,2522013Revenue 2017: $100,598Expenses 2017: $74,942Net Income 2017: $25,6562017Revenue 2018: $107,860Expenses 2018: $109,261Net Income 2018: -$1,4012018Revenue 2019: $308,282Expenses 2019: $279,767Net Income 2019: $28,5152019Revenue 2020: $659,411Expenses 2020: $470,491Net Income 2020: $188,9202020Revenue 2021: $599,293Expenses 2021: $414,562Net Income 2021: $184,7312021Revenue 2022: $1,410,138Expenses 2022: $1,319,933Net Income 2022: $90,2052022Revenue 2023: $1,852,552Expenses 2023: $1,661,665Net Income 2023: $190,8872023Revenue 2024: $1,052,682Expenses 2024: $845,152Net Income 2024: $207,5302024

Highlighted filing

2013

Revenue$17,995
Expenses$743
Net Income$17,252
Filing Detail Status

This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview

Mission

Provide funding to rare disease research & support affected families

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings